Literature DB >> 12486290

Parkinsonism associated with a serotonin and noradrenaline reuptake inhibitor, milnacipran.

M Arai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12486290      PMCID： PMC1738164          DOI： 10.1136/jnnp.74.1.137

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

Review 1.  Drug-induced parkinsonism in the elderly: incidence, management and prevention.

Authors:  José Luis López-Sendón; María Angeles Mena; Justo García de Yébenes
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

2.  Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan.

Authors:  Teruhiko Higuchi; Mike Briley
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

3.  Parkinsonism secondary to duloxetine use: a case report.

Authors:  Arzu Bayrak; Bugra Cetin; Handan Meteris; Sermin Kesebir
Journal:  North Clin Istanb       Date:  2015-12-25

4.  Sertraline-induced Hemichorea.

Authors:  Emilia M Gatto; Victoria Aldinio; Virginia Parisi; Gabriel Persi; Gustavo Da Prat; Maria Bres Bullrich; Pilar Sanchez; Galeno Rojas
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-12-18

5.  Respecting the Patient's Choice: A Case of Possible Drug-Induced Parkinsonism.

Authors:  Megan R Undeberg; Kimberly C McKeirnan; David Easley
Journal:  Pharmacy (Basel)       Date:  2022-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.